Table 1.
Case | Sex | Age | Diagnosis | Localization | WHO Grade | Serum MMPs (vol × 10−3) | Tissue MMP-9 | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
MMP-9 (240 kDa) | MMP-9 (130 kDa) | MMP-9 (92 kDa) | MMP-2 (72 kDa) | Neoplastic vessels | Neoplastic glial cells | ||||||
1 | M | 43 | A | Cerebellum | I | nd | nd | 243 | 574 | 0 | 0 |
2 | F | 17 | A | Encephalon | I | 207 | 415 | 1482 | 249 | 0 | 0 |
3 | M | 39 | G | Cerebellum | I | 106 | 50 | 1243 | 576 | 0 | 0 |
4 | F | 32 | O | Left temporal lobe | II | 248 | 113 | 1765 | 942 | 0 | +++ |
5 | M | 40 | O | Left frontal lobe | II | 62 | 58 | 1051 | 547 | 0 | +++ |
6 | M | 49 | AO | Right frontal lobe | III | 103 | 123 | 1262 | 410 | 0 | +++ |
7 | F | 82 | AO | Right temporal lobe | III | 342 | 214 | 1684 | 893 | 0 | ++ |
8 | F | 73 | AO | Left frontal lobe | III | 185 | 102 | 1262 | 359 | 0 | ++ |
9 | M | 73 | AO | Encephalon | III | 110 | 61 | 708 | 310 | 0 | ++ |
10 | M | 68 | GMB | Left temporal lobe | IV | 88 | 38 | 1015 | 460 | ++ | 0 |
11 | M | 56 | GMB | Left temporal lobe | IV | 111 | 115 | 1394 | 493 | ++ | ++ |
12 | M | 48 | GMB | Left frontal lobe | IV | 47 | nd | 667 | 464 | +++ | + |
13 | M | 62 | GMB | Right temporal lobe | IV | 140 | nd | 1190 | 566 | ++ | + |
14 | F | 76 | GMB | Right parietal lobe | IV | 82 | 61 | 892 | 540 | ++ | ++ |
15 | M | 77 | GMB | Encephalon | IV | 117 | nd | 1096 | 392 | Not done | Not done |
16 | M | 75 | GMB | Right parietal lobe | IV | 194 | 96 | 1408 | 205 | Not done | Not done |
17 | M | 58 | GMB | Left temporal lobe | IV | 203 | nd | 1361 | 1026 | 0 | + |
18 | F | 63 | GMB | Right temporal lobe | IV | 101 | nd | 1130 | 526 | ++ | ++ |
19 | M | 78 | GMB | Right temporal lobe | IV | 162 | 61 | 470 | 70 | 0 | + |
20 | F | 45 | GMB | Left frontal lobe | IV | 77 | nd | 1117 | 308 | Not done | Not done |
A astrocytoma, G ganglioglioma, O oligodendroglioma, AO anaplastic oligodendroglioma, GMB glioblastoma multiforme, MMP matrix-metalloproteinase, nd not detectable, 0 no signal, + <10 %, ++ 10–30 %, +++ 30 %